Demant EBITDA 2012-2023 | WILYY
- Demant EBITDA for the quarter ending December 31, 2023 was $M, a NAN% increase year-over-year.
- Demant EBITDA for the twelve months ending December 31, 2023 was $0M, a NAN% increase year-over-year.
- Demant 2023 annual EBITDA was $0.806B, a 26.35% increase from 2022.
- Demant 2022 annual EBITDA was $0.638B, a 13.79% decline from 2021.
- Demant 2021 annual EBITDA was $0.74B, a 137.35% increase from 2020.
Demant Annual EBITDA (Millions of US $) |
|
---|---|
2023 | $806 |
2022 | $638 |
2021 | $740 |
2020 | $312 |
2019 | $340 |
2018 | $422 |
2017 | $425 |
2016 | $301 |
2015 | $335 |
2014 | $1,666 |
2013 | $318 |
2012 | $284 |
2011 | $318 |
Demant Quarterly EBITDA (Millions of US $) |
|
---|---|
2023-12-31 | |
2022-12-31 | |
2022-06-30 | |
2021-12-31 | |
2021-06-30 | |
2020-12-31 | |
2020-06-30 | |
2019-12-31 | |
2019-06-30 | |
2018-12-31 | |
2018-06-30 | |
2017-12-31 | |
2017-06-30 | |
2016-12-31 | |
2016-06-30 | |
2015-12-31 | |
2014-06-30 | |
2013-12-31 | |
2013-06-30 | |
2012-12-31 | |
2012-06-30 | |
2011-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $9.370B | $3.257B |
Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $180.765B | 23.67 |
Stryker (SYK) | United States | $129.618B | 31.04 |
Boston Scientific (BSX) | United States | $112.981B | 35.99 |
Medtronic (MDT) | Ireland | $100.927B | 15.11 |
EssilorLuxottica (ESLOY) | France | $99.128B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $40.586B | 0.00 |
Haleon (HLN) | United Kingdom | $37.716B | 27.53 |
ResMed (RMD) | United States | $28.121B | 26.40 |
Terumo (TRUMY) | Japan | $24.403B | 34.46 |
Koninklijke Philips (PHG) | Netherlands | $22.841B | 18.13 |
Zimmer Biomet Holdings (ZBH) | United States | $22.328B | 14.26 |
Baxter (BAX) | United States | $17.045B | 12.12 |
Insulet (PODD) | United States | $14.134B | 62.67 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.833B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $7.790B | 25.48 |
BellRing Brands (BRBR) | United States | $7.453B | 35.06 |
Lantheus Holdings (LNTH) | United States | $5.565B | 13.87 |
GN Store Nord (GNNDY) | Denmark | $4.222B | 23.71 |
Haemonetics (HAE) | United States | $4.215B | 20.79 |
Perrigo (PRGO) | Ireland | $3.501B | 10.61 |
Prestige Consumer Healthcare (PBH) | United States | $3.437B | 16.35 |
Neogen (NEOG) | United States | $3.386B | 32.56 |
ICU Medical (ICUI) | United States | $2.893B | 25.54 |
Envista Holdings (NVST) | United States | $2.858B | 11.79 |
TG Therapeutics (TGTX) | United States | $2.749B | 77.35 |
Green Thumb Industries (GTBIF) | United States | $2.552B | 49.96 |
Agios Pharmaceuticals (AGIO) | United States | $2.448B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.225B | 12.35 |
LeMaitre Vascular (LMAT) | United States | $1.847B | 54.13 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.804B | 0.00 |
Warby Parker (WRBY) | United States | $1.592B | 0.00 |
InMode (INMD) | Israel | $1.532B | 8.14 |
AdaptHealth (AHCO) | United States | $1.332B | 9.90 |
Verano Holdings (VRNOF) | United States | $1.246B | 0.00 |
AtriCure (ATRC) | United States | $1.084B | 0.00 |
Owens & Minor (OMI) | United States | $1.033B | 9.00 |
National Vision Holdings (EYE) | United States | $1.028B | 32.72 |
BioLife Solutions (BLFS) | United States | $0.987B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.771B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.679B | 14.46 |
Evolus (EOLS) | United States | $0.679B | 0.00 |
PetIQ (PETQ) | United States | $0.656B | 21.21 |
VAREX IMAGING (VREX) | United States | $0.602B | 14.16 |
Surmodics (SRDX) | United States | $0.599B | 37.54 |
Quanterix (QTRX) | United States | $0.506B | 0.00 |
ZimVie (ZIMV) | United States | $0.498B | 42.44 |
Canopy Growth (CGC) | Canada | $0.491B | 0.00 |
Valneva SE (VALN) | France | $0.488B | 0.00 |
Biote (BTMD) | United States | $0.463B | 10.67 |
Jin Medical (ZJYL) | China | $0.403B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.394B | 0.00 |
Cerus (CERS) | United States | $0.325B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.315B | 10.14 |
Zynex (ZYXI) | United States | $0.296B | 40.52 |
MacroGenics (MGNX) | United States | $0.266B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.254B | 25.19 |
Aurora Cannabis (ACB) | Canada | $0.252B | 0.00 |
Sanara MedTech (SMTI) | United States | $0.243B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.236B | 14.85 |
Omeros (OMER) | United States | $0.235B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.233B | 0.00 |
High Tide (HITI) | Canada | $0.178B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.160B | 0.00 |
FitLife Brands (FTLF) | United States | $0.153B | 21.76 |
Capricor Therapeutics (CAPR) | United States | $0.153B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.150B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.137B | 0.00 |
Veru (VERU) | United States | $0.123B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.104B | 0.00 |
Fonar (FONR) | United States | $0.101B | 10.26 |
Brainsway (BWAY) | Israel | $0.101B | 0.00 |
InterCure (INCR) | Israel | $0.092B | 15.46 |
Cellectar Biosciences (CLRB) | United States | $0.090B | 0.00 |
Chimerix (CMRX) | United States | $0.079B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.073B | 4.75 |
MariMed (MRMD) | United States | $0.069B | 0.00 |
Safety Shot (SHOT) | United States | $0.060B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
Modular Medical (MODD) | United States | $0.051B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.049B | 0.00 |
Bright Green (BGXX) | United States | $0.048B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
Apyx Medical (APYX) | United States | $0.046B | 0.00 |
United-Guardian (UG) | United States | $0.041B | 14.90 |
Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Exagen (XGN) | United States | $0.032B | 0.00 |
Nephros (NEPH) | United States | $0.022B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.021B | 0.00 |
Agape ATP (ATPC) | $0.016B | 0.00 | |
Trinity Biotech (TRIB) | Ireland | $0.016B | 0.00 |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.013B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.011B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
FSD PHARMA (HUGE) | Canada | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
Sharps Technology (STSS) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.003B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.001B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.000B | 0.00 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |